My PCR
Create Account
Logo PCR

19 May 2026

TAVI

TAVI for degenerated surgical aortic bioprotheses: procedural challenges

Session comprising selected EuroPCR 2026 clinical cases submissions

Moderators: S. Worthley, S. Manukyan
Speakers: B. Aipov, I. Fernández, V. Kalogera, P. Cervinka, D. Da Silva Correia, B. Gonska

Summary

This session addresses the procedural challenges inherent in transcatheter aortic valve implantation (TAVI) for degenerated surgical aortic bioprostheses. It covers high-risk valve-in-valve implantation cases as last-resort therapies, management of drifting bioprostheses, and interventions in failed small non-fracturable valves threatening coronary arteries. Techniques such as BASILICA and coronary protection during valve-in-valve procedures are highlighted, alongside strategies for managing degenerated transcatheter valves within surgical valves, emphasizing procedural innovation and risk mitigation.

Presentations available when logged in:

  • High risk aortic valve-in-valve implantation in degenerated surgical bioprosthesis as a last resort
  • Drifting Perceval - TAVI drops the anchor
  • TAVI in a failed small bioprosthetic non-fracturable valve menacing left main
  • Valve-in-valve procedure using new bioprosthesis with BASILICA and protection of the right coronary artery
  • Aortic valve-in-valve with high risk of coronary obstruction
  • Pushing the limits: managing a degenerated transcatheter valve within a surgical aortic valve
Related Content
TAVI versus SAVR in aortic stenosis, is the debate still relevant in 2026? Structural and Valvular Interventions: EuroPCR 2026 highlights TAVI: LIVE Educational Case from Cleveland Clinic - London, UK
Recommended for you
Share your work with the Global Heart Team at #PCRLV PROTECT the head-to-head: Comparison of cerebral protection devices in TAVR PCRonline @ TCT 2025 - The international perspective